Factors affecting brain health in hemodialysis patients
Official title: Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients: an Observational Study
Run by Huashan Hospital · NCT04433455 · Data updated 2026-11-12
This study looks at how different factors affect brain health in people aged 50 to 85 who have been on hemodialysis for over three months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 85 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Huashan Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | June 1, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT04433455 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are hemodialysis patients aged 50 to 85 years with a dialysis history of over three months.
✕Probably not a fit
Patients with severe infections, anemia, mental illnesses, metabolic diseases, or abnormal liver function may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates how various factors influence cerebrovascular disease and cognitive function in patients undergoing hemodialysis. The research focuses on patients aged between 50 and 85 years who have been on dialysis for more than three months. By analyzing the relationship between hemodialysis and cognitive impairment, the study aims to identify potential risk factors and outcomes associated with brain health in this population.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of cognitive impairment in hemodialysis patients.
How similar studies have gone: While there have been studies on cognitive impairment in hemodialysis patients, this specific focus on cerebrovascular disease and cognition is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. maintenance hemodialysis patients who are younger than 85 years old and older than 50 years old, regardless of gender 2. dialysis vintage is greater than 3 months; Exclusion Criteria: 1. Those with severe infection and anemia (Hb \<60g / L); 2. Those with severe mental illness, metabolic diseases and immune system diseases; 3. Patients with abnormal liver function
Where it's running
-
Huashan Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: Jing Chen — Huashan Hospital
- Study coordinator: Jing Chen
- Email: chenjing1998@fudan.edu.cn
- Phone: 862152889325
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A digital tool for assessing cognitive impairment in stroke survivors
This study is testing a new digital tool that helps stroke survivors check for thinking and memory problems on their own to improve their care after a stroke.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
-
Bioimpedance Spectroscopy for Fluid Changes in Hemodialysis Patients
This study tests whether raw bioimpedance data can help doctors gauge fluid changes in people on hemodialysis and guides fluid removal decisions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.